Back
Berry Corp (bry) Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
1
BRY
Berry Corp (bry)
Last Price:
4.33
Seasonality Move:
-2.98%
Sell
47
APLS
Apellis Pharmaceuticals
Last Price:
29.28
Seasonality Move:
20.78%
Sell
1
Berry Corp (bry) (BRY)
is a Sell
Is Berry Corp (bry) a Buy, Sell or Hold?
- The current Berry Corp (bry) [BRY] share price is $4.33. The Score for BRY is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- BRY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $29.26. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRY Stock Price Chart
What is Berry Corp (bry)'s stock price today?
-
The Berry Corp (bry) share price today is $4.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRY is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $29.26
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
BRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 29.48 | Sell |
Chaikin Money Flow: | -1586135 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.86 - 5.42) | Sell |
Bollinger Bands (100): | (5.17 - 6.49) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 52.74 | Buy |
Chaikin Money Flow: | 179519 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.95 - 28.71) | Buy |
Bollinger Bands (100): | (29.49 - 39.35) | Sell |
BRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.95 | Sell |
20-day SMA: | 5.09 | Sell |
50-day SMA: | 5.23 | Sell |
200-day SMA: | 6.59 | Sell |
8-day EMA: | 4.81 | Sell |
20-day EMA: | 5.03 | Sell |
50-day EMA: | 5.32 | Sell |
200-day EMA: | 6.31 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.88 | Buy |
20-day SMA: | 28.02 | Buy |
50-day SMA: | 30.86 | Sell |
200-day SMA: | 43.85 | Sell |
8-day EMA: | 28.92 | Buy |
20-day EMA: | 28.61 | Buy |
50-day EMA: | 30.58 | Sell |
200-day EMA: | 40.41 | Sell |
Berry Corp (bry) Earnings Growth & BRY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.21 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Berry Corp (bry) Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |